Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat

Metabolism: Clinical and Experimental

Volumn 45, Issue 7, 1996, Pages 865-872

  Stevens, M J ^a   Lattimer, S A ^a   Feldman, E L ^a   Helton, E D ^a   Millington, D S ^a   Sima, A A F ^a   Greene, D A ^a  

^a Box 0678 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCARNITINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); FATTY ACID; INOSITOL; OUABAIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOSE RESPONSE; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; TIBIAL NERVE;

EID: 0030008666     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90161-4     Document Type: Article

References (58)

1. Horrobin DF: Gamma linolenic acid. Rev Contemp Pharmacother 1:1-41, 1990
2. Cameron NE, Cotter MA, Robertson S: Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40:532-539, 1991
3. Arduini A, Rossi M, Mancinelli G, et al: Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability. Life Sci 47:2395-2400, 1990
4. Brecher P: The interaction of long-chain acyl CoA with membranes. Mol Cell Biochem 57:3-15, 1983
5. Pugliese G, Tilton RG, Williamson JR: Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 7:35-59, 1991
6. Corr PB, Gross RW, Sobel BE: Amphipathic metabolites and membrane dysfunction in ischemia myocardium. Circ Res 55:135-154, 1984
7. Kim J, Kyriazi H, Greene DA: Normalization of Na,K-ATPase activity in isolated membrane fraction from sciatic nerves of streptozotocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 40:558-567, 1991
8. Tahiliani AG, McNeil JH: Diabetes-induced abnormalities in the myocardium. Life Sci 38:959-974, 1986
9. Greene DA, Winegrad AI: Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells. Diabetes 30:967-974, 1981
10. Greene DA, Lattimer SA: Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve. Am J Physiol 246:E311-E318, 1984
11. Das PK, Bray GM, Aguayo AJ, et al: Diminished ouabain sensitive, sodium potassium ATPase activity in sciatic nerves of rats with streptozotocin induced diabetes. Exp Neurol 53:285-288, 1976
12. Greene DA, Lattimer SA: Impaired rat sciatic nerve sodium-potassium adenosine trisphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72:1058-1063, 1983
13. Greene DA, Chakrabarti S, Lattimer SA, et al: Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic BioBreeding rat. J Clin Invest 79:1479-1485, 1987
14. +ATPase activity in peripheral nerve of streptozotocin-diabetic rats: A role for protein kinase C? Diabetologia 31:297-303, 1988
15. Sonobe M, Yasuda H, Hisanaga T, et al: Amelioration of nerve Na/K-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.a-CD in streptozotocin-induced diabetic rats. Diabetes 40:726-730, 1991
16. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 94:853-859, 1994
17. Cameron NE, Cotter MA, Dines KC, et al: Pharmacological manipulation of vascular endothelium function in nondiabetic and streptozotocin-diabetic rats: Effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36:516-522, 1993
18. Borghini I, Geering K, Gjinovci A, et al: In vivo phosphorylation of the Na,K-ATPase a subunit in sciatic nerves of control and diabetic rats: Effects of protein kinase modulators. Proc Natl Acad Sci USA 91:6211-6215, 1994
19. Zhu X, Eichberg J: 1,2-Diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 55:1087-1090, 1990
20. Greene DA, Sima AAF, Stevens MJ, et al: Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage. Diabetes Metab Rev 9:189-217, 1993
21. Greene DA, Sima AAF, Stevens MJ, et al: Complications: Neuropathy, Pathogenetic Considerations. Diabetes Care 15:1902-1925, 1992
22. 2+. FEBS Lett 192:189-193, 1985
23. Katoh N, Wrenn RW, Wisen BC, et al: Substrate proteins for calmodulin-sensitive and phospholipid-sensitive calcium-dependent protein kinase in the heart, and inhibition of their phosphorylation by palmitoylcarnitine. Proc Natl Acad Sci USA 78:4813-4817, 1981
24. Nakadate T, Blumberg PM: Modulation of palmitoylcarnitine of protein kinase C activation. Cancer Res 47:6537-6542, 1987
25. Jackson PS, Strange K: Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux. Am J Physiol 265:C1489-C1500, 1993
26. Gupta S, Sussman I, McArthur CS, et al: Endothelium-dependent inhibition of Na/K-ATPase activity in rabbit aorta by hyperglycemia. J Clin Invest 90:727-732, 1992
27. Fritz IB: Carnitine and its role in fatty acid metabolism. Adv Lipid Res 1:285-334, 1963
28. Lowitt S, Malone JE, Solem A, et al: Acetylcarnitine improves neuronal function in streptozotocin (STZ) diabetic rats. Diabetes 39:155A, 1990 (abstr)
29. Pacifici L, Bellucci A, Piovesan P, et al: Counteraction on experimentally induced diabetic neuropathy by levocarnitine acetyl. Int J Clin Pharmacol Res 12:231-236, 1992
30. Sima AAF, Kamijo M, Cherian PV, et al: Diabetic neuropathy in the BB/W-rat is prevented by acetyl-L-carnitine treatment. Muscle Nerve 1:5244,1994 (abstr)
31. Ido Y, McHowat J, Chang KC, et al: Neural dysfunction and metabolic imbalances in diabetic rats. Diabetes 43:1469-1477, 1994
32. Williamson JR, Arrigoni-Martelli E: The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction. Int J Clin Pharmacol Res 12:247-252, 1992
33. Stevens MJ, Lattimer SA, Kamijo M, et al: Osmotically induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36:608-614, 1993
34. Sima AAF, Hay K: Functional aspects and pathogenetic considerations of the neuropathy in the spontaneously diabetic BB-Wistar rat. Neuropathol Appl Neurobiol 7:341-350, 1981
35. Millington DS, Chace DH: Carnitine and acylcarnitines in metabolic disease diagnosis and management, in Desideria DM (ed): Mass Spectrometry: Clinical and Biochemical Applications, vol 1. New York, NY, Plenum, 1992, pp 299-318
36. Lowry OH, Rosenbrough NJ, Farr AL, et al: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-273, 1951
37. Larsen BR, Grosso DS, Chang SY: A rapid method for taurine quantitation using high performance liquid chromatography. J Chromatogr Sci 18:233-236, 1980
38. Sima AAF, Brismar T: Reversible diabetic nerve dysfunction. Structural correlates to electrophysiological abnormalities. Ann Neurol 18:21-29, 1985
39. Brismar T, Sima AAF, Greene DA: Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 21:504-507, 1987
40. Greene DA, Lewis RA, Brown MJ, et al: Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat. Diabetes 31:573-578, 1982
41. Greene DA, Winegrad AI: In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural components of peripheral nerve. Diabetes 28:878-887, 1979
42. +-ATPase inhibits the activity of the enzyme. Proc Natl Acad Sci USA 88:11359-11362, 1991
43. Khatami M, Cernadas M, Geroff AJ, et al: Direct regulation of Na-dependent myoinositol transport by sugars in retinal pigment epithelium: Role of phorbol ester and staurosporin. Membr Biochem 9:263-277, 1990
44. Frohlich J, Seccombe DW, Hahn P, et al: Effect of fasting on free and esterifled carnitine levels in human serum and urine: Correlation with serum levels of non-esterified fatty acids and beta-hydroxybutyrate. Metabolism 27:555-561, 1978
45. Cantley LC: Structure and mechanism of the Na,K-ATPase. Curr Top Bioenerg 11:201-237, 1981
46. Lingrel JB, Orlowski J, Shull MM, et al: Molecular genetics of the Na,K-ATPase. Prog Nucleic Acid Res 38:37-89, 1990
47. Shull GE, Greeb J, Lingrel JB: Molecular cloning of three distinct forms of the Na,K-ATPase a-subunit from rat brain. Biochemistry 25:8125-8132, 1986
48. McDonough AA, Geering K, Farley RA: The sodium pump needs its B subunit. FASEB J 4:1598-1605, 1990
49. Sweadner KJ: Isozymes of the Na/K-ATPase. Biochim Biophys Acta 988:185-220, 1989
50. Urayama O, Shutt H, Sweadner KJ: Identification of three isozyme proteins of the catalytic subunit of the Na,K-ATPase in rat brain. J Biol Chem 264:8271-8280, 1989
51. Mata M, Siegel GJ, Hieber V, et al: Differential distribution of the Na,K-ATPase a isoform mRNAs in the peripheral nervous system. Brain Res 546:47-54, 1991
52. +-ATPase in diabetic nerve by protein kinase C agonists. Am J Physiol 256:E264-E269, 1989
53. Locket MJ, Tomlinson DR: The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na/K pump in streptozotocin-diabetic rats. Br J Pharmacol 105:355-360, 1992
54. Greene DA, Lattimer-Greene SA, Sima AAF: Pathogenesis of diabetic neuropathy: Role of altered phosphoinositide metabolism. Crit Rev Neurobiol 5:143-219, 1989
55. Powell HC, Garrett RS, Kador PF, et al: Fine-structural localization of aldose reductase and ouabain-sensitive, K-dependent p-nitro-phenylphosphatase in rat peripheral nerve. Acta Neuropathol 81:529-539, 1991
56. Fink DJ, Datta S, Mata M: Isoform specific reduction in Na,K-ATPase catalytic (a) subunits in the nerve of rats with streptozotocin-induced diabetes. J Neurochem 63:1782-1786, 1994
57. Mata M, Datta S, Jin C-F, et al: Differential axonal transport of individual Na,K-ATPase catalytic (a) subunit isoforms in rat sciatic nerve. Brain Res 618:295-298, 1993
58. Landdown D, Ritchie JM: The binding of titrated ouabain to mammalian non-myelinated nerve fibres. J Physiol 207:529-537, 1970